文献速递外周动脉疾病

CHA2DS2-VASc评分对外周动脉疾病血管内介入治疗后对比剂肾病的预测价值

The Predictive Value of the CHA2DS2-VASc Score in the Development of Contrast-Induced Nephropathy after Endovascular Intervention in Peripheral Artery Disease.
PubMed 文献 · Ann Vasc Surg · 2025-03-26

该研究纳入2个中心754例接受血管内介入的外周动脉疾病患者,按CHA2DS2-VASc评分分为低(<3)和高(≥3)组,回顾性观察对比剂肾病(CIN)发生。178例(23.6%)发生CIN,其中151例(84.8%)在高评分组(P<0.001)。CHA2DS2-VASc评分是CIN的独立预测因子(OR 1.574,95%CI 1.298-1.907,P<0.001),切点2.5预测CIN的灵敏度85%、特异度42%。

要点

  • CHA2DS2-VASc评分是外周动脉疾病血管内介入后CIN的独立预测因子(OR 1.574,95%CI 1.298-1.907,P<0.001)。
  • 178例(23.6%)发生CIN,其中151例(84.8%)位于CHA2DS2-VASc评分高(≥3)组(P<0.001)。
  • CHA2DS2-VASc评分切点2.5预测CIN的灵敏度85%、特异度42%。

核心结论

  • CHA2DS2-VASc评分是外周动脉疾病患者血管内介入治疗后对比剂肾病发生的独立预测因子。

研究设计与样本

  • 研究纳入2个中心754例连续接受血管内介入治疗的外周动脉疾病患者。
  • 计算每例患者的CHA2DS2-VASc评分并分为低(<3)和高(≥3)组,回顾性监测CIN发生并分为CIN阳性(CIN+)和CIN阴性(CIN-)组。
  • 采用单因素和多因素回归分析识别CIN的独立预测因子,所有统计分析显著性水平为P<0.05。

主要发现

  • 754例患者中178例(23.6%)发生CIN,其中151例(84.8%)发生在CHA2DS2-VASc评分高组(P<0.001)。
  • CIN(+)组CHA2DS2-VASc评分显著高于CIN(-)组(P<0.001)。
  • 回归分析识别CHA2DS2-VASc评分(OR 1.574,95%CI 1.298-1.907,P<0.001)、基线肌酐(OR 2.296,95%CI 1.580-3.335,P<0.001)和血红蛋白(OR 0.915,95%CI 0.844-0.992,P<0.001)为独立风险因素。
  • CHA2DS2-VASc评分切点2.5预测CIN的灵敏度85%、特异度42%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Contrast-induced nephropathy (CIN) is a frequent complication of endovascular interventions for peripheral artery disease (PAD). It is linked to renal dysfunction, extended hospital stays, increased cardiovascular events, and higher mortality rates. The CHA2DS2-VASc score, widely utilized for assessing cardioembolic risk and guiding anticoagulation therapy in nonvalvular atrial fibrillation, encompasses risk factors that overlap with those of CIN. This study investigates whether the CHA2DS2-VASc score can predict CIN in PAD patients undergoing endovascular interventions. METHODS: The study included 754 consecutive PAD patients who underwent endovascular procedures at 2 centers. Each patient's CHA2DS2-VASc score was calculated and categorized into low (<3) and high (≥3) groups. Patients were retrospectively monitored for CIN development and divided into CIN-positive (CIN+) and CIN-negative (CIN-) groups. Univariate and multivariate regression analyses were performed to identify independent predictors of CIN, and a significance level of P < 0.05 was used for all statistical analyses. RESULTS: Of the 754 patients, 178 (23.6%) developed CIN, with 151 (84.8%) occurring in the high CHA2DS2-VASc score group (P < 0.001). The CHA2DS2-VASc score was significantly higher in the CIN(+) group compared to the CIN(-) group (P < 0.001). Regression analysis identified the CHA2DS2-VASc score (odds ratio [OR]: 1.574, 95% confidence interval [CI]: 1.298-1.907, P < 0.001), baseline creatinine (OR: 2.296, 95% CI: 1.580-3.335, P < 0.001), and hemoglobin (OR: 0.915, 95% CI: 0.844-0.992, P < 0.001) as independent risk factors. A CHA2DS2-VASc score cutoff of 2.5 predicted CIN with 85% sensitivity and 42% specificity. CONCLUSION: The CHA2DS2-VASc score is an independent predictor of the development of CIN in patients with PAD undergoing endovascular intervention.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Evsen A, Aktan A, Kılıç R, et al. The Predictive Value of the CHA2DS2-VASc Score in the Development of Contrast-Induced Nephropathy after Endovascular Intervention in Peripheral Artery Disease. Ann Vasc Surg. 2025. PMID: 40154953. doi:10.1016/j.avsg.2025.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。